Dr. Fitzgerald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plaza Suite 365c
Los Angeles, CA 90024Phone+1 310-825-2448Fax+1 310-206-8606
Education & Training
- UCLA School of Public HealthPh.D., 1997 - 2005
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1996 - 1999
- UCLA David Geffen School of Medicine/UCLA Medical CenterChief Residency, Internal Medicine, 1996 - 1997
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1993 - 1996
- Tufts University School of MedicineMPH, 1989 - 1993
- Tufts University School of MedicineClass of 1993
- Santa Clara UniversityMBA, 1986 - 1989
- Santa Clara UniversityB.S., 1982 - 1986
Certifications & Licensure
- CA State Medical License 1995 - 2026
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Rheumatology Fellows' Appreciation Award UCLA, 2012
- Distinguished Board Leadership Award Arthritis Foundation Southern California Chapter, 2007
- Join now to see all
Clinical Trials
- Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout Start of enrollment: 2024 Apr 10
Roles: Principal Investigator, Contact
- UR+AIMS Gout Wearable Skin Uric Acid Monitor Study Start of enrollment: 2024 Sep 30
Roles: Contact, Principal Investigator
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout Start of enrollment: 2024 Jan 23
Roles: Contact
Publications & Presentations
PubMed
- 144 citationsDysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.Maureen McMahon, Jennifer M. Grossman, Brian J. Skaggs, John FitzGerald, Lori Sahakian
Arthritis and Rheumatism. 2009-08-01 - 924 citationsAmerican College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisBevra H. Hahn, Maureen McMahon, Alan H. Wilkinson, W. Dean Wallace, David I. Daikh
Arthritis Care & Research. 2012-06-01 - 306 citationsProinflammatory high‐density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritisMaureen McMahon, Jennifer M. Grossman, John FitzGerald, Erika Dahlin-Lee, Daniel J. Wallace
Arthritis and Rheumatism. 2006-08-01
Journal Articles
- Reducing gender disparities in post-total knee arthroplasty expectations through a decision aidVolkman ER, FitzGerald JD, BMC Musculoskeletal Disorders, 1/1/2015
- American College of Rheumatology Report on Reasonable Use of Musculoskeletal Ultrasonography in Rheumatology Clinical PracticeMcAlindon T, Kissin E, Nazarian L, Ranganath V, Prakash S, Taylor M, Bannuru RR, Srinivasan S, Gogia M, McMahon MA, Grossman J, Kafaja S, FitzGerald J, Arthritis Care & Research, 1/1/2012
- 2012 American College of Rheumatology Guidelines for Management of Gout Part II: Therapy and Anti-inflammatory Prophylaxis of Acute Gouty ArthritisKhanna D, Khanna P, FitzGerald J*, Singh M, Bae S, Neogi T, Pillinger M, Merril J, et al, Arthritis Care & Research, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE.McMahon M, Sahakian L, Grossman J, Skaggs B, Fitzgerald J, Charles-Schoeman C, Ragavendra N, Gorn A, Karpouzas G, Weisman M, Wallace D, Hahn B, Arthritis Res Ther, 1/1/2012
- Cholesterol Efflux by High Density Lipoproteins Is Impaired in Patients with Active Rheumatoid ArthritisCharles-Schoeman C, Lee YY, Grijalva V, FitzGerald JD, Ranganath VK, Taylor M, McMahon MA, Paulus HE, Reddy ST, Arthritis Rheum, 1/1/2011
- Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) Levels Are Associated with Carotid Plaque Progression in Women with SLEMcMahon MA, Lorenco E, Grossman JM, Sahakian L, FitzGerald JD, Ragavendra N, Charles-Schoeman C, Gorn AH, Weisman MH, Wallace D, Hahn BH, Skaggs B, Arthritis Rheum, 1/1/2011
- Join now to see all
Lectures
- Turning Guidelines into Quality Measures: Development of Gout Quality Measures.Los Angeles, CA - 1/18/2015
- Emerging Therapies for GoutSan Francisco, CA - 1/10/2015
- Updated on Policy, RhMSUS certification and AIUM accreditationBoston, MA - 1/14/2014
- Join now to see all
Press Mentions
- The Doctor Game: Gout No Longer Just a Disease for Blue-BloodsApril 19th, 2021
- 8 Gout Complications You Need to Know AboutJuly 3rd, 2019
Grant Support
- Development of an Informed Decision-Making Intervention to address under-utilization of total knee replacement for African-American patients.”Arthritis Foundation2021–2023
- Development and validation of lens-free polarized microscopy to identify monosodium urate and calcium pyrophosphate crystals from synovial fluid.NIAMS2018–2021
- Impact Of Medicare Policies On Utilization And Outcomes.Agency For Healthcare Research And Quality2002–2005
- Potential Impact Of Bundled Medicare PaymentsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2001
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
External Links
- UCLA Physician summaryhttp://www.uclahealth.org/body.cfm?xyzpdqabc=0&id=479&action=detail&ref=14268
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: